1. Home
  2. LUNG vs KEQU Comparison

LUNG vs KEQU Comparison

Compare LUNG & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • KEQU
  • Stock Information
  • Founded
  • LUNG 1995
  • KEQU 1906
  • Country
  • LUNG United States
  • KEQU United States
  • Employees
  • LUNG N/A
  • KEQU N/A
  • Industry
  • LUNG Industrial Specialties
  • KEQU Medical Specialities
  • Sector
  • LUNG Health Care
  • KEQU Industrials
  • Exchange
  • LUNG Nasdaq
  • KEQU Nasdaq
  • Market Cap
  • LUNG 124.0M
  • KEQU 106.0M
  • IPO Year
  • LUNG 2020
  • KEQU N/A
  • Fundamental
  • Price
  • LUNG $2.67
  • KEQU $36.30
  • Analyst Decision
  • LUNG Buy
  • KEQU
  • Analyst Count
  • LUNG 6
  • KEQU 0
  • Target Price
  • LUNG $11.53
  • KEQU N/A
  • AVG Volume (30 Days)
  • LUNG 366.5K
  • KEQU 5.8K
  • Earning Date
  • LUNG 07-30-2025
  • KEQU 06-25-2025
  • Dividend Yield
  • LUNG N/A
  • KEQU N/A
  • EPS Growth
  • LUNG N/A
  • KEQU 102.06
  • EPS
  • LUNG N/A
  • KEQU 5.90
  • Revenue
  • LUNG $87,473,000.00
  • KEQU $220,026,000.00
  • Revenue This Year
  • LUNG $18.02
  • KEQU N/A
  • Revenue Next Year
  • LUNG $18.17
  • KEQU N/A
  • P/E Ratio
  • LUNG N/A
  • KEQU $6.14
  • Revenue Growth
  • LUNG 19.84
  • KEQU 9.44
  • 52 Week Low
  • LUNG $2.62
  • KEQU $30.33
  • 52 Week High
  • LUNG $9.37
  • KEQU $71.33
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 33.53
  • KEQU 42.93
  • Support Level
  • LUNG $2.62
  • KEQU $36.36
  • Resistance Level
  • LUNG $3.52
  • KEQU $40.39
  • Average True Range (ATR)
  • LUNG 0.23
  • KEQU 1.46
  • MACD
  • LUNG 0.02
  • KEQU -0.40
  • Stochastic Oscillator
  • LUNG 13.46
  • KEQU 0.00

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

Share on Social Networks: